$ICPT INTERCEPT PHARMACEUTICALS, INC. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in INTERCEPT PHARMACEUTICALS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
INTERCEPT PHARMACEUTICALS, INC. Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
Adorini Luciano | Chief Scientific Officer | 12,608 | 1,431,891 | Oct 05 2015 | |||
Adorini Luciano | Chief Scientific Officer | 5,094 | 578,526 | Jul 24 2013 | |||
Adorini Luciano | Chief Scientific Officer | 6,392 | 725,939 | Jan 03 2014 | |||
AKKARAJU SRINIVAS | Director | 477,129 | 54,187,541 | shares bought: 676,705 / shares sold: -23,438 | STRONG BUY | Mar 12 2021 | 16 months ago |
AKKARAJU SRINIVAS | Director | 2,368 | 268,934 | Dec 19 2013 | |||
AKKARAJU SRINIVAS | Director | 7,642 | 867,902 | Nov 13 2014 | |||
BALL BRYAN | Chief Quality Officer | 25,000 | 2,839,250 | shares bought: 25,000 / shares sold: 0 | BUY | Jan 11 2021 | 18 months ago |
Benatti Luca | Director | 1,292 | 146,732 | Dec 15 2014 | |||
BRADBURY DANIEL | Director | 15,811 | 1,795,655 | shares bought: 47,059 / shares sold: 0 | STRONG BUY | Jun 01 2021 | 13 months ago |
Bright Lisa | President, International | 22,012 | 2,499,903 | shares bought: 29,553 / shares sold: -22,630 | BUY | Jul 06 2020 | 24 months ago |
Campagna Jason | Chief Medical Officer | 20,531 | 2,331,706 | shares bought: 16,800 / shares sold: -2,760 | STRONG BUY | Jan 26 2021 | 17 months ago |
Cawkwell Gail | SVP, Med Affairs, Safety & PV | 32,553 | 3,697,044 | shares bought: 22,784 / shares sold: -4,201 | STRONG BUY | May 13 2021 | 14 months ago |
Duncan Barbara Gayle | Chief Accounting Officer | 30,661 | 3,482,170 | shares bought: 0 / shares sold: -437 | STRONG SELL | Oct 05 2016 | |
Duncan Barbara Gayle | Chief Financial Officer | 9,410 | 1,068,694 | Oct 03 2013 | |||
Duncan Barbara Gayle | Chief Financial Officer | 10,708 | 1,216,108 | Jan 03 2014 | |||
Duncan Barbara Gayle | Chief Financial Officer | 14,808 | 1,681,745 | Jul 03 2014 | |||
Duncan Barbara Gayle | Chief Financial Officer | 17,264 | 1,960,672 | Jan 07 2015 | |||
Durso Jerome Benedict | President & CEO | 82,142 | 9,328,867 | shares bought: 94,600 / shares sold: -7,401 | STRONG BUY | Apr 05 2021 | 15 months ago |
Ford David A | Chief Human Resources Officer | 23,711 | 2,692,858 | shares bought: 29,200 / shares sold: -3,609 | STRONG BUY | May 11 2021 | 14 months ago |
Freedberg Jared | General Counsel and Secretary | 44,277 | 5,028,539 | shares bought: 44,277 / shares sold: 0 | BUY | Feb 01 2021 | 17 months ago |
Fundaro Paolo | Director | 5,417,000 | 615,208,690 | shares bought: 14,328 / shares sold: -2,097,749 | STRONG SELL | Aug 17 2020 | 23 months ago |
Fundaro Paolo | Director | 8,803 | 999,757 | Aug 12 2014 | |||
Genextra S.p.A. | 10% Owner | 5,417,000 | 615,208,690 | shares bought: 390,625 / shares sold: -4,632,312 | STRONG SELL | Aug 17 2020 | 23 months ago |
Gottesdiener Keith Michael | Director | 9,953 | 1,130,362 | shares bought: 13,466 / shares sold: 0 | STRONG BUY | Jun 01 2020 | 25 months ago |
Kapadia Sandip | CFO and Treasurer | 40,964 | 4,652,281 | shares bought: 56,200 / shares sold: -9,208 | STRONG BUY | Jan 26 2021 | 17 months ago |
Kim Richard J | President US Comm & Strat Mktg | 20,828 | 2,365,436 | shares bought: 15,200 / shares sold: -4,413 | STRONG BUY | Oct 05 2020 | 21 months ago |
Luca Benatti | Director | 10,721 | 1,217,584 | shares bought: 8,779 / shares sold: 0 | STRONG BUY | Jun 01 2020 | 25 months ago |
McMinn Rachel | Chief Strategy Officer | 16,875 | 1,916,494 | shares bought: 5,000 / shares sold: -2,451 | BUY | Oct 04 2017 | |
Micheli Francesco | 10% Owner | 5,417,000 | 615,208,690 | shares bought: 390,625 / shares sold: -2,845,578 | STRONG SELL | Aug 17 2020 | 23 months ago |
Micheli Francesco | 10% Owner | 5,938,890 | 674,479,737 | Oct 23 2013 | |||
Micheli Francesco | 10% Owner | 6,454,953 | 733,089,012 | Apr 11 2014 | |||
Miller-Rich Nancy | Director | 7,538 | 856,091 | shares bought: 7,538 / shares sold: 0 | STRONG BUY | Jun 01 2020 | 25 months ago |
ORBIMED ADVISORS LLC | Director | 1,120,609 | 127,267,564 | Jul 21 2015 | |||
ORBIMED ADVISORS LLC | Director | 1,485,324 | 168,688,247 | Aug 27 2014 | |||
ORBIMED ADVISORS LLC | Director | 2,151,283 | 244,321,210 | Apr 15 2013 | |||
Patel Sanj K | Director | 452 | 51,334 | Jul 21 2014 | |||
Pruzanski Mark | Director | 506,466 | 57,519,344 | shares bought: 267,940 / shares sold: -216,611 | BUY | May 04 2021 | 14 months ago |
Pruzanski Mark | President and CEO | 406,899 | 46,211,519 | Oct 03 2013 | |||
Pruzanski Mark | President and CEO | 416,635 | 47,317,237 | Jan 03 2014 | |||
Pruzanski Mark | CEO & President | 491,032 | 55,766,504 | Jan 07 2015 | |||
Pruzanski Mark | CEO & President | 486,625 | 55,266,001 | Nov 20 2014 | |||
Regan Daniel Paul | Chief Commerical Officer | 0 | 0 | Mar 06 2013 | |||
Regan Daniel Paul | Chief Commercial Officer | 0 | 0 | Mar 07 2014 | |||
Regan Daniel Paul | Chief Commercial Officer | 1,264 | 143,552 | Jan 07 2015 | |||
Regan Daniel Paul | Chief Commercial Officer | 1,264 | 143,552 | Feb 03 2015 | |||
Richardson Linda M | EVP & Chief Commercial Officer | 26,866 | 3,051,172 | shares bought: 5,531 / shares sold: 0 | BUY | Feb 17 2021 | 17 months ago |
SANTINI GINO | Director | 8,879 | 1,008,388 | shares bought: 7,579 / shares sold: 0 | STRONG BUY | Jun 01 2020 | 25 months ago |
SBLENDORIO GLENN | Director | 15,710 | 1,784,185 | shares bought: 14,608 / shares sold: 0 | STRONG BUY | Jun 01 2021 | 13 months ago |
SBLENDORIO GLENN | Director | 452 | 51,334 | Jul 21 2014 | |||
Shapiro David | Chief Medical Officer | 41,499 | 4,713,041 | shares bought: 35,810 / shares sold: -43,121 | SELL | May 03 2019 | |
Shapiro David | CMO & EVP - Development | 3,000 | 340,710 | Dec 17 2013 | |||
Shapiro David | CMO and EVP - Development | 4,623 | 525,034 | Jan 03 2014 | |||
Shapiro David | CMO and EVP - Development | 14,253 | 1,618,713 | Sep 17 2014 | |||
Shapiro David | CMO and EVP - Development | 18,796 | 2,134,662 | Feb 19 2015 | |||
SILVERSTEIN JONATHAN | Director | 1,259 | 142,985 | Nov 27 2015 | |||
SILVERSTEIN JONATHAN | Director | 285 | 32,367 | Jul 21 2014 | |||
SILVERSTEIN JONATHAN | Director | 609 | 69,164 | Aug 12 2014 | |||
SILVERSTEIN JONATHAN | Director | 1,596,582 | 181,323,818 | Aug 18 2014 | |||
SILVERSTEIN JONATHAN | Director | 1,980 | 224,869 | Nov 12 2013 | |||
SILVERSTEIN JONATHAN | Director | 2,150,634 | 244,247,503 | Oct 16 2012 | |||
Sullivan Ryan T | General Counsel and Secretary | 24,708 | 2,806,088 | shares bought: 52,550 / shares sold: -30,862 | STRONG BUY | Nov 16 2020 | 20 months ago |
TALLARIGO LORENZO | Director | 3,479 | 395,110 | Nov 12 2013 | |||
TALLARIGO LORENZO | Director | 0 | 0 | Jul 09 2014 | |||
VEITINGER KLAUS R DR | Director | 2,816 | 319,813 | Nov 27 2015 | |||
VEITINGER KLAUS R DR | Director | 2,120 | 240,768 | Nov 12 2013 | |||
VEITINGER KLAUS R DR | Director | 2,166 | 245,993 | Nov 12 2014 | |||
VEITINGER KLAUS R DR | Director | 2,166 | 245,993 | Feb 12 2015 | |||
Venezia Rocco | Chief Accounting Officer | 14,289 | 1,622,802 | shares bought: 0 / shares sold: -29 | STRONG SELL | Apr 05 2021 | 15 months ago |
WELCH DANIEL G | Director | 8,060 | 915,374 | shares bought: 7,579 / shares sold: -819 | STRONG BUY | Jun 01 2020 | 25 months ago |
Weyer Christian | EVP, Research & Development | 27,341 | 3,105,117 | shares bought: 47,825 / shares sold: -20,879 | STRONG BUY | Apr 05 2021 | 15 months ago |
WILLIAMS NICOLE | Director | 962 | 109,254 | Nov 23 2015 | |||
WILLIAMS NICOLE | Director | 2,569 | 291,761 | Nov 12 2013 | |||
WILLIAMS NICOLE | Director | 1,465 | 166,380 | Jan 22 2015 | |||
WILLIAMS NICOLE | Director | 3,304 | 375,235 | May 09 2014 |